DE Shaw Research (DESRES) invested heavily in custom silicon for molecular dynamics (MD) to solve protein folding. In contrast, DeepMind's AlphaFold, using ML on experimental data, solved it on commodity hardware. This demonstrates data-driven approaches can be vastly more effective than brute-force simulation for complex scientific problems.

Models like AlphaFold don't solve protein folding from physics alone. They heavily rely on co-evolutionary data, where correlated mutations across species provide strong hints about which amino acids are physically close. This dramatically constrains the search space for the final structure.

Unlike generative tools that always produce an output, BindCraft sometimes yields no passing designs. This "failure" is a valuable feature, acting as a strong negative predictor that saves researchers months of wasted lab effort on low-probability targets. This builds user confidence in the designs that do pass.

An anecdote about a "wonky" BindCraft design with disconnected beta sheets, which experts predicted would fail, highlights a key trend. The resulting binder was one of the best ever produced, suggesting AI models are extracting structural principles that go beyond traditional human "protein literacy" and intuition.

Novonesis has shifted enzyme discovery from the lab to computers. Using AI tools like AlphaFold, they predict protein structures and identify new enzyme families based on structural motifs rather than sequence similarity. This allows them to find novel functionalities much faster than traditional methods.

Contrary to trends in other AI fields, structural biology problems are not yet dominated by simple, scaled-up transformers. Specialized architectures that bake in physical priors, like equivariance, still yield vastly superior performance, as the domain's complexity requires strong inductive biases.

The design tool isn't a passive executor. Its multi-component loss function, optimizing for properties like foldedness, can override a user's chosen binding site if it's suboptimal. This "AI agency" is a key feature that contributes to its high success rate in the lab.

The initial motivation for BindCraft wasn't just to design better proteins, but to avoid the laborious, low-yield process of yeast display screening. This personal frustration with an inefficient workflow drove the development of a computational tool that dramatically increased hit rates from 1-in-1000 to 7-in-10.

AlphaFold 2 was a breakthrough for predicting single protein structures. However, this success highlighted the much larger, unsolved challenges of modeling protein interactions, their dynamic movements, and the actual folding process, which are critical for understanding disease and drug discovery.